Scientists and innovators are developing new microbes, materials, and processes to address the problems of fast fashion - one of the most polluting industries on the planet. We attend the Biofabricate conference every year to track the innovations for our clients and investors.

Cultivated meat approved. Consumer acceptance of GMOs. Market size and investment opportunities.

The Biden Administration has earmarked $2 billion to grow the bioeconomy. In this post, we outline how friends of the blog would depoly those funds. $125M should be spent on media to get people excited about the bioeconomy.

Arye Lipman, founder of the venture capital firm, Mars Bio, recently co-founded LabDAO, an open, community-run network of wet and dry laboratories accelerating progress in the life sciences. Messaginglab founder, Karl Schmieder, sat down with Arye to learn more about decentralized science, LabDAO, and how the world of science might change as people create life science ventures on the blockchain.

You have to figure out your own story and your company’s story in a way that catches people’s attention and makes it interesting. You have to figure out how to tell the story in a way that is memorable - or sticky - and gets your audience asking for more.

I sat down with Ellen to learn more about Aanika Biosciences, Genspace, COVID testing, and the lessons biotech companies could take to increase their storytelling success. What follows are excerpts from our conversation.

I'm back from last week's Built with Biology conference.

Here's a few key takeaways from people I saw on stage and spoke to.

Tom Baruch, a seasoned entrepreneur and venture capitalist, began shifting his VC practice from materials science, IT, and biotechnology to the then-nascent field of synthetic biology in 1997. Over the years, he has funded more than 12 synthetic biology companies and has an enviable track record, never losing money and exiting at 5x to double-digits in as little as 18 months.